Friday 12 June 2009

Carpel Tunnel Syndrome Patients Provide Better Relief

A new study revealed that there is a new non-surgical treatment to cure the symptoms of carpel tunnel syndrome. Researchers compared results between people who had been experiencing symptoms of the condition for at least three months. Patients were randomly assigned to receive either surgery or steroid injections. Results showed no difference in outcomes between the groups over the long term, and in the short term, people who received the injections actually reported better relief of symptoms.

Symptoms of carpel tunnel syndrome are usually treated by splinting and pain relievers such as ibuprofen. In cases that neither of these treatments works, patients choose to have surgery to decompress the nerve. Since steroid injection offers relief from the symptoms, many carpel tunnel syndrome patients will greatly benefit from this innovation.

From Bio-Medicine:
Researchers say a non-surgical treatment is just as good as invasive surgery in relieving painful symptoms associated with carpel tunnel syndrome. Carpal tunnel syndrome is a painful condition of the wrist resulting from compression of the median nerve that runs from the base of the palm up to the forearm affecting people who perform repetitive hand motions, including computer users, dental hygienists, and even golfers and tennis players.

Standard treatment for symptoms of carpel tunnel syndrome includes splinting and pain relievers like ibuprofen. When those methods fail to help, many patients undergo surgery to decompress the nerve. However, another option is to receive steroid injections to relieve symptoms.
Carpel tunnel syndrome causes numbness and pain in the fingers or hand. Some people even have pain in their arms between their hand and elbow. This condition of the wrist resulting from compression of the median nerve that runs from the base of the palm up to the forearm affecting people who perform repetitive hand motions, including computer users, golfers and tennis players.

No comments:

Post a Comment